SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
RGEN

Repligen Corp (RGEN)

NASDAQ: RGEN · Real-Time Price · USD
Healthcare · Medical Instruments & Supplies
179.66+2.73 (+1.54%)
 
Market cap
$11.4B
Analyst consensus
Insider Score
––Not scored
RGEN Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

RGEN analyst forecast

RGEN analyst consensus

No analyst ratings in the last 3 months.

RGEN 12-month price target

$225.00+26.1% upsideaverage of 1 firm
$225.00High
$225.00Low

Best analysts covering RGEN

No firm covering RGEN has enough calls with a finished 1Y holding period to rank yet.

Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.

RGEN analyst ratings

FirmPrice targetAction
Barclays—$225.00+28.7%—2026-10-07
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.